Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Infectious Disease Physician in Weston, FL
NPI: 1164652624Primary Practice Location
CLEVELAND CLINIC HOSPITAL
2950 Cleveland Clinic Blvd, Weston, FL
Primary Employer
Cleveland Clinic Florida a Nonprofit Corporation
my.clevelandclinic.org
HQ Phone
Get M.D. Carla's Phone Numberphone_androidMobile
Get M.D. Carla's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
FL State Medical License
2016 - 2026
NY State Medical License
2012 - 2017
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Infectious Disease
Zucker School of Medicine at Hofstra/Northwell
Fellowship • Infectious Disease
2011 - 2013
NYU Grossman School of Medicine/Brooklyn Campus
Residency • Internal Medicine
2008 - 2011
Medical University of the Americas
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 145 | 401 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 86 | 93 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 69 | 153 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 64 | 95 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 47 | 47 |
Authors: Malhotra, Prashant, Luka, Arthur, McWilliams, Carla S, Poeth, Kaitlin G, Schwartz, Rebecca, Elfekey, Mohammed, Balwan, Sandy
Journal: South Med J
Oerskovia Species Bacteremia in a Diabetic Patient.
Authors: Katerina Oikonomou
Journal: J Glob Infect Dis
Successful mobile extracorporeal membrane oxygenator for COVID-19 severe respiratory failure.
Authors: Jose Navia, Jaime Hernandez-Montfort, Nicolas Brozzi, Mauricio Velez, Jeffrey Jacobs, Roberto Cubeddu, Steven Minear, Cedric Sheffield, Edward Noguera, Elsy Navas
Journal: J Card Surg
Publication Date: 2020-10-10
Lead Sponsor: Vanderbilt University Medical Center
Collaborators: National Center for Advancing Translational Sciences (NCATS), Dolly Parton
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: pathogen reduced SARS-CoV-2 convalescent plasma
Lead Sponsor: The Cleveland Clinic
Collaborators: Kiniksa Pharmaceuticals, Ltd.
Intervention / Treatment: DRUG: Placebos, DRUG: Mavrilimumab
Lead Sponsor: Eli Lilly and Company
Collaborators: GlaxoSmithKline, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd., Vir Biotechnology, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Bebtelovimab, DRUG: Etesevimab, DRUG: Bamlanivimab, DRUG: VIR-7831
